nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2006-10-4-98-102nefr-709Research ArticleНАБЛЮДЕНИЯ ИЗ ПРАКТИКИPRACTICAL NOTESСЛУЧАЙ ДИАГНОСТИКИ БОЛЕЗНИ АНДЕРСОНА–ФАБРИ (ANGIOKERATOMA CORPORIS DIFFUSUM UNIVERSALE)A CASE OF THE DIAGNOSIS OF ANDERSON–FABRY DISEASE (ANGIOKERATOMA CORPORIS DIFFUSUM UNIVERSALE)СиповскийВ. Г.SipovskyV. G.ТитоваВ. А.TitovaV. A.КлеминаИ. К.KleminaI. K.СмирновА. В.SmirnovA. V.ДобронравовВ. А.DobronravovV. A.КаюковИ. Г.KayukovI. G.ЕсаянА. М.EssaianA. M.Научно-исследовательский институт нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. ПавловаRussian Federation20061004200610498102Copyright © Сиповский В.Г., Титова В.А., Клемина И.К., Смирнов А.В., Добронравов В.А., Каюков И.Г., Есаян А.М., 20062006Сиповский В.Г., Титова В.А., Клемина И.К., Смирнов А.В., Добронравов В.А., Каюков И.Г., Есаян А.М.Sipovsky V.G., Titova V.A., Klemina I.K., Smirnov A.V., Dobronravov V.A., Kayukov I.G., Essaian A.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/709
.
.
болезнь Андерсона–Фабриглобтризилцерамидынефробиопсиямиелинодобные телаAnderson–Fabry diseaseglobtrizilceramidesmyelin-like bodiesReferencesBranton M, Schiffmann R, Kopp JB. Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 2002;13 [Suppl 2]:134-138Branton M, Schiffmann R, Kopp JB. Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 2002;13 [Suppl 2]:134-138Desnick RJ, Brady R, Barranger J et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003;138 (4):338-346Desnick RJ, Brady R, Barranger J et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003;138 (4):338-346Meikle P, Panieri E. Simonson H et al. Newborn screening for lysosomal disorders: clinical evaluatuion of two-tier strategy. Pediatrics 2004;114:909-916Meikle P, Panieri E. Simonson H et al. Newborn screening for lysosomal disorders: clinical evaluatuion of two-tier strategy. Pediatrics 2004;114:909-916Kang DH, Kamellis J, Hugo C et al. Role of microvascular endothelium in progressive renal disease.J Am Soc Nephrol 2002;13: 806-816Kang DH, Kamellis J, Hugo C et al. Role of microvascular endothelium in progressive renal disease.J Am Soc Nephrol 2002;13: 806-816Alroy J, Sabnis S, Kopp JB. Renal pathology in Fabry disease. J Am Soc Nephrol 2002; 13 [suppl 2]: 134-138Alroy J, Sabnis S, Kopp JB. Renal pathology in Fabry disease. J Am Soc Nephrol 2002; 13 [suppl 2]: 134-138Sessa A, Meroni MG, Battini G et al. Renal involvement in Anderson-Fabry disease. J Nephrol 2003;16(2): 310-313Sessa A, Meroni MG, Battini G et al. Renal involvement in Anderson-Fabry disease. J Nephrol 2003;16(2): 310-313Whybra C, Kampmann C, Willers I et al. Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 2001; 24: 715-724Whybra C, Kampmann C, Willers I et al. Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 2001; 24: 715-724Kotanko P, Kramar R, Devrnja D et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol 2004;15:1323-1329Kotanko P, Kramar R, Devrnja D et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol 2004;15:1323-1329Karen JK, Hale EK, Ma L. Angiokeratoma corporis diffusum (Fabry disease).Dermatology online J 2005;11: 8Karen JK, Hale EK, Ma L. Angiokeratoma corporis diffusum (Fabry disease).Dermatology online J 2005;11: 8Peters FP, Vermeulen A, Kho TL. Anderson-Fabry’s disease: alpha-galactosidase deficiency. Lancet 2001; 375:138-140Peters FP, Vermeulen A, Kho TL. Anderson-Fabry’s disease: alpha-galactosidase deficiency. Lancet 2001; 375:138-140Sessa A, Tosoni A, Nebuloni M et al. Renal ultrastructural findings in Anderson-Fabry disease.J Nephrol 2002;15:109-112Sessa A, Tosoni A, Nebuloni M et al. Renal ultrastructural findings in Anderson-Fabry disease.J Nephrol 2002;15:109-112
The authors declare that there are no conflicts of interest present.